Back to Screener

Healthcare

Spero Therapeutics, Inc.(SPRO)

Live Price

Offline

$2.28

+8.06% today

1Y Change

-22.18%

Window

Jun 23, 2025 โ†’ Jun 18, 2026

Market Cap
$140.00M
Revenue Growth
+24.3%
EPS Growth
+111.8%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 23, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Spero Therapeutics, Inc. (SPRO) is a Healthcare stock with a market cap of $140.00M and listed on NASDAQ. The stock last traded around $2.28 and down 22.2% across the available one-year price window (Jun 23, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +24.3%, EPS growth of +111.8%, a dividend yield of 0.0%. What stands out right now is revenue +24.3%, EPS +111.8%, free cash flow +46.2% with operating margin -0.0% and ROIC -0.0%. Valuation is more restrained than many high-expectation growth names at P/E 16.2 and price/sales 2.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SPRO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

SPRO

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

SPRO Max Drawdown

-39.80%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for SPRO and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 13, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 13, 26
โ€”
Est -0.18
โ€”
โ€”
Est 43339.0B
โ€”
May 13
โ€”
Mar 26, 26
โœ“
0.53
Est -0.20
+365.0%
41297.0B
Est 26000.0B
+58.8%
Mar 26
โ€”
Nov 13, 25
โœ“
-0.13
Est -0.25
+48.0%
3048.0B
Est 12000.0B
-74.6%
Nov 13
โ€”
Aug 12, 25
โœ“
-0.03
Est -0.38
+92.1%
11802.0B
Est 11000.0B
+7.3%
Aug 12
โ€”
May 13, 25
โœ“
-0.25
Est -0.55
+54.5%
5874.0B
Est 11000.0B
-46.6%
May 13
โ€”
Mar 27, 25
โœ—
-0.38
Est -0.35
-8.6%
9356.0B
Est 6200.0B
+50.9%
Mar 27
โ€”
Nov 14, 24
โœ—
-0.32
Est -0.27
-18.5%
13469.0B
Est 4133.3B
+225.9%
Nov 14
โ€”
Aug 5, 24
โœ“
-0.33
Est -0.35
+5.7%
6017.0B
Est 4900.0B
+22.8%
Aug 5
โ€”
May 15, 24
โœ—
-0.24
Est -0.07
-242.9%
4204.0B
Est 21530.0B
-80.5%
May 15
โ€”
Mar 13, 24
โœ“
0.96
Est -0.10
+1060.0%
71827.0B
Est 18630.0B
+285.5%
Mar 13
โ€”
Nov 13, 23
โœ“
0.02
Est -0.15
+113.3%
25473.0B
Est 26630.0B
-4.3%
Nov 13
โ€”
Aug 10, 23
โœ“
-0.23
Est -0.29
+20.7%
788.0B
Est 11030.0B
-92.9%
Aug 10
โ€”
May 11, 23
โœ“
-0.25
Est -0.35
+28.6%
740.0B
Est 1000.0B
-26.0%
May 11
โ€”
Mar 30, 23
โœ“
0.55
Est 0.04
+1169.3%
46301.6B
Est 22870.0B
+102.5%
Mar 30
โ€”
Nov 14, 22
โœ“
-0.33
Est -0.34
+2.9%
1082.0B
Est 5416.7B
-80.0%
Nov 14
โ€”
Aug 10, 22
โœ“
-0.87
Est -0.88
+1.1%
896.0B
Est 1433.3B
-37.5%
Aug 10
โ€”
May 16, 22
โœ—
-1.01
Est -0.87
-16.1%
247.0B
Est 1925.0B
-87.2%
May 16
โ€”
Mar 31, 22
โœ—
-0.90
Est -0.80
-12.5%
2744.0B
Est 4950.0B
-44.6%
Mar 31
โ€”
Nov 10, 21
โ€”
-0.70
Est -0.70
0.0%
3064.0B
Est 3064.0B
0.0%
Nov 10
โ€”
Aug 5, 21
โœ“
-0.63
Est -0.77
+18.2%
5148.0B
Est 5148.0B
0.0%
Aug 5
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener